splenic marginal zone lymphoma |
Disease ID | 763 |
---|---|
Disease | splenic marginal zone lymphoma |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:10) HP:0012191 | B-cell lymphoma | 1 HP:0000099 | Glomerular nephritis | 1 HP:0001901 | Abnormally shaped erythrocytes | 1 HP:0002960 | Autoimmune condition | 1 HP:0001878 | Haemolytic anaemia | 1 HP:0100495 | Mastocytosis | 1 HP:0002665 | Lymphoma | 1 HP:0001903 | Anemia | 1 HP:0012578 | Membranous glomerulonephritis | 1 HP:0001890 | Autoimmune hemolytic anemia | 1 |
Disease ID | 763 |
---|---|
Disease | splenic marginal zone lymphoma |
Manually Symptom | UMLS | Name(Total Manually Symptoms:6) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:2) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:8) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs113488022 | 22531170 | 673 | BRAF | umls:C0349632 | BeFree | In this study we investigated the application of a BRAF V600E mutation-specific antibody (clone VE1) to differentiate HCL from HCL mimics, such as HCL variant and splenic marginal zone lymphoma. | 0.001085767 | 2012 | BRAF | 7 | 140753336 | A | T,G,C |
rs113488022 | 25480661 | 673 | BRAF | umls:C0349632 | BeFree | BRAF-V600E is the key driver mutation in HCL and distinguishes it from other B-cell lymphomas, including HCL-like leukemias/lymphomas (HCL-variant and splenic marginal zone lymphoma). | 0.001085767 | 2015 | BRAF | 7 | 140753336 | A | T,G,C |
rs121913364 | 22133769 | 673 | BRAF | umls:C0349632 | BeFree | A BRAF K601E mutation was detected in a patient with splenic marginal zone lymphoma. | 0.001085767 | 2012 | BRAF | 7 | 140753334 | T | G,C |
rs387907272 | 23321251 | 10584 | COLEC10 | umls:C0349632 | BeFree | Using either assay, MYD88 L265P was detected in 97 of 104 (93%) WM and 13 of 24 (54%) IgM MGUS patients and was either absent or rarely expressed in samples from splenic marginal zone lymphoma (2/20; 10%), CLL (1/26; 4%), multiple myeloma (including IgM cases, 0/14), and immunoglobulin G MGUS (0/9) patients as well as healthy donors (0/40; P < 1.5 × 10(-5) for WM vs other cohorts). | 0.000271442 | 2013 | MYD88 | 3 | 38141150 | T | C |
rs387907272 | 25723115 | 4615 | MYD88 | umls:C0349632 | BeFree | After reclassification, MYD88 L265P was detected in 13/86 (15%) SMZL and in 19/24 LPL (79%) cases. | 0.000814326 | 2015 | MYD88 | 3 | 38141150 | T | C |
rs387907272 | 23355535 | 4615 | MYD88 | umls:C0349632 | BeFree | MYD88 (L265P) was detected in 58/58 (100%) patients with WM, 36/77 (47%) with IgM-MGUS, 5/84 (6%) with SMZL, and 3/52 (4%) with B-CLPD. | 0.000814326 | 2013 | MYD88 | 3 | 38141150 | T | C |
rs387907272 | 23321251 | 160364 | CLEC12A | umls:C0349632 | BeFree | Using either assay, MYD88 L265P was detected in 97 of 104 (93%) WM and 13 of 24 (54%) IgM MGUS patients and was either absent or rarely expressed in samples from splenic marginal zone lymphoma (2/20; 10%), CLL (1/26; 4%), multiple myeloma (including IgM cases, 0/14), and immunoglobulin G MGUS (0/9) patients as well as healthy donors (0/40; P < 1.5 × 10(-5) for WM vs other cohorts). | 0.000271442 | 2013 | MYD88 | 3 | 38141150 | T | C |
rs387907272 | 23321251 | 4615 | MYD88 | umls:C0349632 | BeFree | Using either assay, MYD88 L265P was detected in 97 of 104 (93%) WM and 13 of 24 (54%) IgM MGUS patients and was either absent or rarely expressed in samples from splenic marginal zone lymphoma (2/20; 10%), CLL (1/26; 4%), multiple myeloma (including IgM cases, 0/14), and immunoglobulin G MGUS (0/9) patients as well as healthy donors (0/40; P < 1.5 × 10(-5) for WM vs other cohorts). | 0.000814326 | 2013 | MYD88 | 3 | 38141150 | T | C |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |